BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22496565)

  • 1. A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors.
    Xiong W; Wu X; Li F; Cheng K; Rice KC; Lovinger DM; Zhang L
    J Neurosci; 2012 Apr; 32(15):5200-8. PubMed ID: 22496565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors.
    Hejazi N; Zhou C; Oz M; Sun H; Ye JH; Zhang L
    Mol Pharmacol; 2006 Mar; 69(3):991-7. PubMed ID: 16332990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine.
    Yang Z; Aubrey KR; Alroy I; Harvey RJ; Vandenberg RJ; Lynch JW
    Biochem Pharmacol; 2008 Oct; 76(8):1014-23. PubMed ID: 18755158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
    Houser SJ; Eads M; Embrey JP; Welch SP
    Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.
    Xiong W; Cheng K; Cui T; Godlewski G; Rice KC; Xu Y; Zhang L
    Nat Chem Biol; 2011 May; 7(5):296-303. PubMed ID: 21460829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of glycine receptor α1 subunits in cannabinoid-induced analgesia.
    Lu J; Fan S; Zou G; Hou Y; Pan T; Guo W; Yao L; Du F; Homanics GE; Liu D; Zhang L; Xiong W
    Neuropharmacology; 2018 May; 133():224-232. PubMed ID: 29407767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-dependent modulation of α2- and α3-glycine receptor subunits by ethanol.
    McCracken LM; Trudell JR; McCracken ML; Harris RA
    Alcohol Clin Exp Res; 2013 Dec; 37(12):2002-10. PubMed ID: 23895467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells.
    Stanslowsky N; Jahn K; Venneri A; Naujock M; Haase A; Martin U; Frieling H; Wegner F
    Addict Biol; 2017 Sep; 22(5):1329-1342. PubMed ID: 27027565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.
    Athanasiou A; Clarke AB; Turner AE; Kumaran NM; Vakilpour S; Smith PA; Bagiokou D; Bradshaw TD; Westwell AD; Fang L; Lobo DN; Constantinescu CS; Calabrese V; Loesch A; Alexander SP; Clothier RH; Kendall DA; Bates TE
    Biochem Biophys Res Commun; 2007 Dec; 364(1):131-7. PubMed ID: 17931597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.
    Walentiny DM; Gamage TF; Warner JA; Nguyen TK; Grainger DB; Wiley JL; Vann RE
    Eur J Pharmacol; 2011 Apr; 656(1-3):63-7. PubMed ID: 21300050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
    J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.
    Xiong W; Cui T; Cheng K; Yang F; Chen SR; Willenbring D; Guan Y; Pan HL; Ren K; Xu Y; Zhang L
    J Exp Med; 2012 Jun; 209(6):1121-34. PubMed ID: 22585736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
    Chang YH; Lee ST; Lin WW
    J Cell Biochem; 2001; 81(4):715-23. PubMed ID: 11329626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs.
    Kumar A; Kindig K; Rao S; Zaki AM; Basak S; Sansom MSP; Biggin PC; Chakrapani S
    Nat Commun; 2022 Aug; 13(1):4862. PubMed ID: 35982060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.
    Hegde VL; Hegde S; Cravatt BF; Hofseth LJ; Nagarkatti M; Nagarkatti PS
    Mol Pharmacol; 2008 Jul; 74(1):20-33. PubMed ID: 18388242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for a high-potency open-channel block of Kv1.5 channel by the endocannabinoid anandamide.
    Moreno-Galindo EG; Barrio-Echavarría GF; Vásquez JC; Decher N; Sachse FB; Tristani-Firouzi M; Sánchez-Chapula JA; Navarro-Polanco RA
    Mol Pharmacol; 2010 May; 77(5):751-8. PubMed ID: 20133392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of apamin-sensitive medium afterhyperpolarization current by anandamide and its role in excitability control in cultured hippocampal neurons.
    Wang W; Zhang K; Yan S; Li A; Hu X; Zhang L; Liu C
    Neuropharmacology; 2011 May; 60(6):901-9. PubMed ID: 21272594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.